Literature DB >> 7847825

Barrett's oesophagus: mucin composition, neuroendocrine cells, p53 protein, cellular proliferation and differentiation.

K Jaskiewicz1, J Louw, N Anichkov.   

Abstract

There is strong association of Barrett's oesophagus (BO) with adenocarcinoma. The sequence of events preceding malignancy appears to be reflux oesophagitis - ulceration - BO - dysplasia. One hundred and five biopsies of heterotopic columnar epithelium were stained for H&E, PAS/Alcian Blue and HID/Alcian Blue for the routine histology and neutral/acidic sialo- and sulphomucin staining. Other sections were silver impregnated by the Grimelius technique. Immunohistochemical techniques were applied for the assessment of the accumulation of p53 protein, "S" phase of the replication cell cycle using proliferating cell nuclear antigen (PCNA), marked for cell differentiation and proliferation using EGF and TGFa. 105 cases of heterotopic columnar epithelium consisted of 74 cases of BO, 25 junctional and 7 corpus mucosa. Dysplastic BO (n = 9) showed similar amount of sulphomucin and endocrine cell number when compared to non-dysplastic. PCNA study revealed a close similarity between dysplastic, indefinite for dysplasia and non-dysplastic, mucosal positive counts. Growth factors activity was significantly higher in dysplastic and indefinite than in non-dysplastic, but no such difference was found between dysplastic and indefinite for dysplasia BO. There was a significant concurrent p53 expression in dysplastic and indefinite for dysplasia BO. In conclusion, the practical utility of mucin stainings, endocrine cell count, assessment of cell proliferation and differentiation by PCNA, EGF and TGFa seems to be limited in differentiation of the dysplastic and indefinite for dysplasia BO. Altered expression of p53, particularly in combination with EGF and TGFa, may be useful in studying these lesions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7847825

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Biochemical analysis of the stress protein response in human oesophageal epithelium.

Authors:  D Hopwood; S Moitra; B Vojtesek; D A Johnston; J F Dillon; T R Hupp
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

Review 2.  Role of p53 assessment in management of Barrett's esophagus.

Authors:  A K Kubba; N A Poole; A Watson
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

3.  Predicting Neoplastic Progression in Barrett's Esophagus.

Authors:  Jean S Wang; Marcia I Canto
Journal:  Ann Gastroentol Hepatol       Date:  2010-06

4.  Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study.

Authors:  G S Arul; M Moorghen; N Myerscough; D A Alderson; R D Spicer; A P Corfield
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

5.  Chromogranin A-positive tumor cells in human esophageal squamous cell carcinomas.

Authors:  Aping Yuan; Jinzhong Liu; Yiqing Liu; Guanglin Cui
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

6.  Platelet 12-lipoxygenase and stem cells in Barrett's esophagus.

Authors:  Kazimierz Jaœkiewicz; Ewa Iżycka-Œwieszewska; Maria Janiak; Wiesława Lysiak-Szydłowska; Krystian Adrych; Jeannette Reinartz; Jerzy Jankun; Ewa Skrzypczak-Jankun
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

7.  Mucosal endocrine cell micronests and single endocrine cells following neo-adjuvant therapy for adenocarcinoma of the distal oesophagus and oesophagogastric junction.

Authors:  Colin J R Stewart; Simon Hillery
Journal:  J Clin Pathol       Date:  2007-09-24       Impact factor: 3.411

8.  Immunohistochemical study of neuroendocrine cells at the gastric cardia mucosa.

Authors:  M Voutilainen; M Juhola; R Pitkänen; M Färkkilä; P Sipponen
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.